Purdue Pharma’s $7.4 Billion Chapter 11 Plan Poised for Court Confirmation
December 24, 2025 | Washington, D.C. — MedLegalNews.com — Purdue Pharma’s long-running Chapter 11 bankruptcy case is nearing a decisive moment, as a federal court prepares to confirm a revised $7.4 billion reorganization plan designed to resolve thousands of opioid-related claims nationwide. The confirmation would mark one of the most significant mass tort resolutions in […]
Purdue Pharma’s $7.4 Billion Chapter 11 Plan Poised for Court Confirmation Read Post »









